Valeant Pharma ($VRX) announced that its Chairman and CEO Michael Pearson will be on medical leave of absence, effectively, following him being treated for a severe case of Pneumonia. The company said it has created an office of the CEO, including its General Counsel, Group Chairman and CFO, to serve in an interim capacity.